CRSP CRISPR Therapeutics AG has potential for future profitability, but it is currently unprofitable. The company operates in the high-growth field of gene editing. Burning money fast. not a good buy that price, see you under 30 dollar/share, very risky now
EDIT is way better than CRSP Don't let boomers convince you to buy their billions worth of bags compared to a smaller mcap. If they're bullish on gene stocks that means EDIT will go way higher than any of those
CRSP Just a quick chart for Crisper. Today's candle is a solid close above the upper trendline acting as resistance. There are also 3 bullish signals with the MA Cross, MacdLE, and a strong bullish divergence on the Money Flow Index. I expect the price to move 8.5% to approx $55.45 and posibly 16% to $59.37 over the next 3-4 weeks.
CRSP pondering this outline. I think biotech is going to be big over the next few decades as, face it, it's the only thing that is going to rescue human longevity due to the way we've destroyed our demographics as a species.